The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Xcovery Holdings, Inc., announced that the FDA accepted the New Drug Application (NDA) for ensartinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor ...
read more
Andy Cowan has been appointed President at Particle Measuring Systems (PMS), taking over from Mark Fleiner, President of Spectris Scientific and ...
read more
Thursday, February 29, 2024
Nanoform Finland Plc announced it had received positive results from its own pre-clinical, in-vivo study of a nanocrystalline-enabled apalutamide oral...
read more
Wednesday, February 21, 2024
Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and ...
read more
Wednesday, January 03, 2024
Ampersand Biomedicines, a multi-product platform company developing medicines that act specifically at the site of disease and nowhere else, today ...
read more
Thursday, December 14, 2023
Distek, Inc., a well-reputed leader in laboratory pharmaceutical instruments, is excited to announce the release of the latest software update for the...
read more
Wednesday, November 15, 2023
Absci Corporation and Almirall S.A. announced a drug discovery partnership aimed to develop and commercializing AI-designed therapeutics to fight ...
read more
Tuesday, November 14, 2023
Alvotech and JAMP Pharma Group announced today Health Canada has granted JAMP Pharma marketing authorization for AVT04, a biosimilar to Stelara® (...
read more
Tuesday, November 14, 2023
Absci Corporation and Almirall S.A. announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight ...
read more
Thursday, November 09, 2023
AstraZeneca and Eccogene entered an exclusive license agreement for ECC5004, an investigational oral once-daily glucagon-like peptide 1 receptor ...
read more
Hyloris Pharmaceuticals SA announced that Maxigesic® IV has been approved for the relief of mild to moderate pain and for the management of moderate ...
read more
Thursday, September 28, 2023
HitGen announced a partnership with The Structural Genomics Consortium ("SGC"), a public-private partnership that supports the discovery of new ...
read more
Wednesday, September 06, 2023
XtalPi, a provider of AI-powered drug discovery solutions, and Parthenon Therapeutics, a clinical-stage biotechnology company dedicated to ...
read more
Roquette announced an agreement to acquire Qualicaps and reinforce its position as a major supplier to the pharmaceutical industry.
read more
UPMC announced a collaboration with PharmaLogic Holdings Corp. to facilitate the development of novel radiopharmaceuticals for the diagnosis and ...
read more